183 results on '"Jin, Aishun"'
Search Results
2. Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T cell receptors for cancer immunotherapy targeting hotspot driver mutations
3. Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer
4. SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2− breast cancer
5. Cbl-b inhibition promotes less differentiated phenotypes of T cells with enhanced cytokine production
6. Real-world effectiveness of an intranasal spray A8G6 antibody cocktail in the post-exposure prophylaxis of COVID-19
7. Integrated analysis of single-cell and bulk RNA sequencing data reveals the association between hypoxic tumor cells and exhausted T cells in predicting immune therapy response
8. DNA-scaffolded multivalent vaccine against SARS-CoV-2
9. Bivalent intra-spike binding provides durability against emergent Omicron lineages: Results from a global consortium
10. Rapid cloning of antigen-specific T-cell receptors by leveraging the cis activation of T cells
11. A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery
12. Targeting tumor-infiltrating CCR8+ regulatory T cells induces antitumor immunity through functional restoration of CD4+ Tconvs and CD8+ T cells in colorectal cancer.
13. Dynamic Survival Risk Prognostic Model and Genomic Landscape for Atypical Teratoid/Rhabdoid Tumors: A Population-Based, Real-World Study
14. Neutrophil depletion attenuates antibody-mediated rejection in a renal transplantation mouse model.
15. Neutrophil depletion attenuates antibody-mediated rejection in a renal transplantation mouse model
16. Identification of an HLA-A*11:01-restricted neoepitope of mutant PIK3CA and its specific T-cell receptors for cancer immunotherapy targeting hotspot driver mutations
17. Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
18. Time-restricted feeding alleviates metabolic implications of circadian disruption by regulating gut hormone release and brown fat activation.
19. A first-in-human clinical study of an intranasal spray of a cocktail containing two synergetic antibodies neutralizes Omicron BA.4/5
20. Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection
21. Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
22. MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer
23. CRISPR-based knockout screening identifies the loss of MIEF2 to enhance oxaliplatin resistance in colorectal cancer through inhibiting the mitochondrial apoptosis pathway
24. Structures of Omicron spike complexes and implications for neutralizing antibody development
25. A cocktail containing two synergetic antibodies broadly neutralizes SARS-CoV-2 and its variants including Omicron BA.1 and BA.2
26. Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies
27. Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants
28. TRAIL-R1-Targeted CAR-T Cells Exhibit Dual Antitumor Efficacy
29. A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains
30. Organoids from Patient Biopsy Samples can Predict the Response of BC Patients to Neoadjuvant Chemotherapy
31. T Cell Immunity Evaluation and Immunodominant Epitope T Cell Receptor Identification of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein in COVID-19 Convalescent Patients
32. A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days
33. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine
34. p38 inhibition enhances TCR-T cell function and antagonizes the immunosuppressive activity of TGF-β
35. MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma
36. A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding
37. IL-21 Optimizes the CAR-T Cell Preparation Through Improving Lentivirus Mediated Transfection Efficiency of T Cells and Enhancing CAR-T Cell Cytotoxic Activities
38. TRAIL-R1-targeted chimeric antigen receptor T cells exhibit dual antitumor effects
39. Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
40. A rapid and efficient single-cell manipulation method for screening antigen-specific antibody–secreting cells from human peripheral blood
41. A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
42. Ultrapotent SARS-CoV-2 neutralizing antibodies effectively block new-emerging mutational variants
43. Identification of Cross-Reactive CD8+ T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants
44. A rapid and efficient screening system for neutralizing antibodies and its application for SARS-CoV-2
45. Screening of Antigen-Specific Antibody-Secreting Cells
46. Characterization of a fully human monoclonal antibody against extracellular domain of matrix protein 2 of influenza A virus
47. A key linear epitope for a potent neutralizing antibody to SARS-CoV-2 S-RBD
48. A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBD
49. Extracellular loop domain of small (S)-hepatitis B surface antigen (HBsAg) play a major role in preventing the infection of hepatitis B virus: Result of comprehensive analysis of monoclonal antibodies obtained from S-HBsAg-vaccinated healthy individuals
50. Analysis of the clinical significance of DCLK1+ colorectal cancer using novel monoclonal antibodies against DCLK1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.